Netana Hadas Markovitz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccines | 1 | 2022 | 843 | 0.430 |
Why?
|
Hospice Care | 2 | 2021 | 678 | 0.220 |
Why?
|
Burkitt Lymphoma | 1 | 2023 | 338 | 0.180 |
Why?
|
Terminal Care | 2 | 2021 | 1770 | 0.160 |
Why?
|
Models, Educational | 1 | 2021 | 375 | 0.150 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2018 | 364 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1375 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2023 | 1203 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5717 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2021 | 1085 | 0.090 |
Why?
|
Learning | 1 | 2021 | 1759 | 0.090 |
Why?
|
Affect | 1 | 2019 | 1495 | 0.090 |
Why?
|
Delirium | 1 | 2023 | 1696 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.080 |
Why?
|
Caregivers | 1 | 2020 | 2302 | 0.070 |
Why?
|
Students, Medical | 1 | 2021 | 1964 | 0.070 |
Why?
|
Curriculum | 1 | 2021 | 3782 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3626 | 0.050 |
Why?
|
Neoplasms | 2 | 2023 | 22371 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4530 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8747 | 0.040 |
Why?
|
Axilla | 1 | 2022 | 623 | 0.040 |
Why?
|
Quality of Life | 2 | 2019 | 13490 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2023 | 3231 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2022 | 737 | 0.040 |
Why?
|
Hospices | 1 | 2020 | 245 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8741 | 0.030 |
Why?
|
Cytarabine | 1 | 2019 | 695 | 0.030 |
Why?
|
Anthracyclines | 1 | 2019 | 286 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1271 | 0.030 |
Why?
|
Aged | 7 | 2023 | 171502 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13677 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21207 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14783 | 0.030 |
Why?
|
Humans | 10 | 2023 | 768171 | 0.030 |
Why?
|
Educational Measurement | 1 | 2021 | 1260 | 0.030 |
Why?
|
Hospitalization | 2 | 2023 | 10840 | 0.030 |
Why?
|
Patient Preference | 1 | 2020 | 946 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2663 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3800 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81760 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54924 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2018 | 2197 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11244 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2337 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5315 | 0.020 |
Why?
|
Palliative Care | 1 | 2021 | 3643 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1907 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8542 | 0.020 |
Why?
|
Male | 5 | 2023 | 364731 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3490 | 0.020 |
Why?
|
Female | 5 | 2023 | 397187 | 0.020 |
Why?
|
Anxiety | 1 | 2019 | 4672 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26379 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 223487 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8230 | 0.010 |
Why?
|
Adult | 2 | 2020 | 223646 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59626 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65379 | 0.010 |
Why?
|